熱門資訊> 正文

Alzament Neuro重新获得纳斯达克合规性

2026-09-16 20:35

Alzamend Neuro(ALZN) 0

Alzamend Neuro (ALZN) received a notification letter from Nasdaq dated September 14, 2026, informing Alzamend that it has regained compliance.
In the compliance notice, Nasdaq stated that Alzamend complies with the equity rule and the matter is now closed.

More on Alzamend Neuro

Seeking Alpha’s Quant Rating on Alzamend Neuro
Historical earnings data for Alzamend Neuro
Financial information for Alzamend Neuro

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。